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Introduction
To analyze the effectiveness of pre-study questionnaires
in identifying at-risk patients as well as estimate the pre-
valence of chronic kidney disease (CKD), nephrogenic
systemic fibrosis (NSF) risk factors, and other co-mor-
bidities in patients scheduled to undergo magnetic reso-
nance angiography (MRA) gadonlinium-based contrast
agents (GBCA) studies.
Purpose
Nephrogenic systemic fibrosis (NSF) is a rare, but ser-
ious, disease that is highly linked to the use of GBCAs
in patients with renal insufficiency. Identification of
these patients is considered vital prior to performing
any such study. Thus, many institutions have adminis-
tered pre-study questionnaires to patients in efforts to
determine the degree of any pre-existing renal disease.
However, identification of patients with renal dysfunc-
tion using this method has proven challenging due to
many patients denying any history of renal disease on
patient questionnaires, despite having low glomerular
filtration rate (GFR) values. As a result, some institu-
tions have instituted same-day point of care (POC)
serum creatinine testing to estimate GFR values for all
patients scheduled to undergo GBCA studies. In this
study, we sought to quantify the effectiveness of these
questionnaires relative to same-day POC data in identi-
fying patients with renal insufficiency.
Methods
This study was based upon a HIPAA-compliant and
IRB-approved retrospective review of patients’ records,
and informed consent of patients was not required.
Patent demographics, co-morbidities, contrast type,
POC serum creatinine values, and responses to pre-
study questionnaires regarding knowledge of patients’
history of renal dysfunction were recorded for all
patients undergoing a lower extremity magnetic reso-
nance angiography exam in a single year. Patients were
compared with respect to demographic, co-morbidity,
and contrast data according to their CKD status. Patient
questionnaire results were also compared to their
POC-based CKD classification.
Results
Of 199 total patients, 72 patients had stage 3 CKD, 6
patients had stage 4 CKD, and 7 patients had stage 5
CKD. Co-morbidities including transplant status, pre-
sence of diabetes, hypertension, coronary artery disease,
and smoking status showed significant differences
among the CKD groups. Only 6.9% of stage 3 patients
were aware of any history of renal dysfunction, whereas
50% of stage 4 and 100% of stage 5 patients admitted
any history of renal dysfunction via questinonnaires
(Figure 1).
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Figure 1 Admission of renal dysfunction by CKD group.
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Conclusion
A pre-study questionnaire alone cannot be relied upon
in screening at-risk patients, and POC creatinine testing
can more reliably detect renal dysfunction in patients
scheduled to undergo MRA GBCA studies.
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